Hypersensitivity to anastrozole or any component in the product.
Premenopausal women.
Patients with severe kidney failure.
Patients with moderate to severe liver failure.
Pregnant or breastfeeding women.
Concomitant use of: Selective estrogen receptor modulators (e.g., tamoxifen, raloxifene); Other aromatase inhibitors (e.g., exemestrane, formestane, letrozole).
Not recommended for use in children
Other Services
Country
Account